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Abstract 
Purpose: The present study aimed to induce elevated symptom reports through the presentation of 
unpleasant cues in patients with irritable bowel syndrome (IBS) and examine whether applying an 
emotion regulation technique (affect labeling) can reduce symptom reporting in patients.  
Methods: Patients diagnosed with IBS (N=29) and healthy controls (N=26) were presented with 
six picture series (3 pleasant, 3 unpleasant) under 3 within-subject conditions: merely viewing, 
emotional labeling or content (non-emotional) labeling. Each picture viewing trial was followed by 
affect ratings and a symptom checklist, consisting of general arousal and IBS-specific symptoms.  
Results: Viewing unpleasant pictures led to overall increased symptom reports, both for arousal 
and gastrointestinal symptoms, in both groups. Labeling the pictures did not reduce these effects 
significantly, although a trend towards less arousal symptoms after unpleasant cues emerged in the 
patient group only, especially during emotional labeling.  
Conclusions: Current findings indicate that the mere presentation of unpleasant cues can induce 
elevated symptom reports in IBS patients. The results of the labeling manipulation provide modest 
support for the effectiveness of emotion regulation strategies in reversing these effects of 
unpleasant cues in patients suffering from functional syndromes. Methodological issues that may 
have confounded present results are discussed.  
 
Keywords: emotion regulation, affect labeling, symptom reporting, IBS patients.  
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Introduction 
Physical symptoms not adequately explained by organic dysfunction are common in 
primary and secondary care [1-3]. In specialties like gastroenterology, gynecology and neurology, 
cases with unexplained symptomatology can exceed 50% [3,4]. Although specialty-specific 
functional syndromes have been proposed, these different syndromes share many features and are 
often considered to reflect common core mechanisms [5].  
One of the most prominent shared features is their relation to emotional distress. Patients 
with functional syndromes show high levels of comorbid depression and anxiety disorders [6-8], 
while experimentally induced negative affect has been found to intensify the perception of 
physical symptoms more in functional syndromes patients compared to controls or patients with 
explained disease [9-11]. Although quite robust, this link among negative affect and medically 
unexplained symptoms remains poorly understood.  
Among the functional syndromes, Irritable Bowel Syndrome (IBS) in particular has been 
linked to mechanisms related to emotional distress, like perceptual hypersensitivity to visceral 
sensations [12,13]. Specifically, IBS patients show larger responses of the defensive system in 
anticipation of visceral stimulation [14] and greater activations in brain areas related to affective 
processing of internal sensations (thalamus, insular and ACC sub-regions and amygdala) 
compared to healthy people [15]. Additionally, patients exhibit reduced activations of prefrontal 
areas during visceral stimulation, suggesting a deficit to down-regulate these emotional responses 
[15-17]. 
Importantly, induced state negative affect (NA) (e.g. by auditory stress) has been found to 
enhance the unpleasantness of visceral stimulation more strongly in IBS patients than in controls 
[10]. However, the role of such affective influences on the experience of symptoms has not been 
sufficiently explored. While IBS research has focused almost exclusively on how stress alters the 
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perception of actual visceral stimulation, research on non-clinical samples has shown that even 
slight affective manipulations by means of a picture viewing paradigm not involving 
experimentally induced physiological stimulation, can induce physical symptom reports especially 
in high habitual symptom reporters in daily life. These studies suggest that state NA can have top-
down effects on symptom perception by activating symptom schemata in memory in this selected 
group [18,19]. However, this paradigm demonstrating the role of state NA in the top-down 
mechanisms involved in symptom perception has not yet been examined in patients.       
In addition to its effects on the subjective experience of visceral sensations, momentary 
distress during visceral stimulation has been found to result in more brain activations in insula, 
ACC and VLPFC and less activation in DLPFC for IBS patients compared to controls [20]. This 
suggests that under stressful conditions, IBS patients fail to recruit inhibitory mechanisms to 
regulate pain. These findings, along with studies showing deficient emotion regulation in other 
functional syndromes [21] and theoretical views connecting chronic pain with reduced self-
regulation [22], propose a reduced ability for self- and emotion regulation as an important 
mechanism influencing the relation between NA and unexplained symptoms. They further 
advocate the possible benefits of interventions targeting inhibitory control over emotional 
reactions in reducing symptomatology in functional syndrome patients. 
One way to activate inhibitory processes is the utilization of emotion regulation techniques 
to down-regulate affective reactions. Such techniques have been linked with increased activations 
in prefrontal and cingulate areas and parallel reductions in amygdala activation [23,24]. Similar 
effects on brain activity and self-reported affect have been reported for implicit emotion regulation 
strategies, like affect labeling [25-27]. Merely assigning emotional labels to unpleasant stimuli has 
been found to reduce negative affect in both non-clinical and patient samples [27,28]. Although it 
is not yet clear which aspect of affect labeling produces such regulatory effects, it is assumed that 
labeling an emotion initiates a more cognitive or semantic processing of the emotion which entails 
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the activation of prior conceptual knowledge about emotions [29]. This process seems to disrupt or 
inhibit the more automatic components of emotion response, thus resulting in incidental down-
regulation of emotion [30].   
Patients with functional syndromes, who are less successful in intentionally employing 
emotion regulation strategies [21], could possibly benefit by an implicit strategy like affect 
labeling. Supporting evidence comes from a study using a non-clinical sample, which showed that 
labeling compared to merely viewing unpleasant pictures reduced momentary symptom reports, 
especially in people reporting frequent unexplained symptoms in daily life [31]. However, it is not 
known whether such a brief intervention would have a similar effect in patients.     
Present study  
The present study aimed to examine a) whether the mere presentation of unpleasant 
pictures induces elevated symptom reports in patients with IBS, and b) whether an implicit 
emotion regulation strategy, namely affective labeling, can inhibit these effects on symptom 
reports. To this end, a picture viewing paradigm previously used to induce elevated symptom 
reports [18, 19] was combined with an affect labeling task [31] and administered to IBS patients 
and healthy controls. Specifically, participants viewed pleasant and unpleasant pictures under three 
within-subject conditions: a) merely viewing the pictures, b) choosing a non-emotional label for 
the pictures (content labeling) and c) choosing an emotional label for the pictures (emotion 
labeling). Each picture viewing condition was followed by a symptom checklist.  
We expected that a) IBS patients would report more symptoms than controls, especially 
gastrointestinal ones, in all conditions, b) unpleasant pictures would result in increased symptom 
reports, especially in the patient group, and c) the two labeling conditions would reduce symptom 
reports compared to merely viewing unpleasant pictures as previously found [31], but this effect 
was expected to be more pronounced in the patient group.  
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Methods 
Participants 
The sample consisted of IBS patients (N=29, 7 males, Mage=37.55, SDage=12.46, range=18-
54) recruited from the general gastroenterology and neurogastroenterology outpatient clinics of the 
University Hospital Gasthuisberg, Leuven. The IBS diagnosis was made by gastroenterologists 
based on the Rome III criteria for IBS [32] and after the exclusion of organic dysfunctions as 
potential sources for patients’ symptoms. A healthy control group (N=26, 4 males, Mage=36.50, 
SDage=12.65, range=19-55) was recruited via local advertisements. The groups did not differ in 
age or gender proportions.  
Exclusion criteria for the control group were any self-reported current disease or chronic 
medical or mental disorder or medication intake (except for oral contraceptives or occasional anti-
allergic medication). For the patient group, mental disorders and medication use were not an 
exclusion criterion; 21 patients were taking medication (antireflux, antispasmodic, anti-
inflammation, analgesics), 2 patients reported minor physical problems, 4 patients other functional 
syndromes and 3 psychological problems. Participants were also excluded post-hoc if they did not 
experience the expected changes in pleasantness during the task, that is pleasantness ratings lower 
than average (< 5 on a 1-9 scale) for at least one of the negative trials and higher than neutral for at 
least one of the positive trials (3 patients, 1 control). Participants received monetary 
reimbursement for their participation. The study was approved by the Medical Ethical Committee 
of UZ Gasthuisberg.  
Tasks  
Modified Affect Labeling task. A modified Affect Labeling task, consisting of six picture viewing 
trials (3 pleasant/3 unpleasant), previously applied on a student sample [31], was used. Pictures 
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were selected from the International Affective Picture System (IAPS; [33])1 based on ratings 
provided by students in other studies by our group, and grouped into six sets of 10 pictures, so that 
sets of similar pleasantness did not differ on pleasantness or arousal ratings2. Based on norms by 
Mikels et al. [34], each pleasant set included five pictures depicting excitement (e.g. skiing) and 
five depicting contentment (e.g. cute babies) and each unpleasant set included five pictures 
depicting sadness (e.g. cemetery) and five fear (e.g. gun).  
During each trial, 10 IAPS pictures were presented in the upper part of the screen for 6 sec 
each (no inter-stimulus interval) under 3 within-subject conditions: a) VIEW: merely watch the 
pictures, b) LABEL EMOTION: select from two emotion words presented below the picture (two 
out of: excited, content, sad, afraid) the one most applicable to the depicted emotion and c) 
LABEL CONTENT: select from two words presented below the picture (two out of: object, 
animal, human, landscape) the one most applicable to the content of the picture.  
Each trial started with a word cue stating which task participants had to perform, while at 
the end of each picture set, participants completed affect ratings and a symptom checklist.  
Measures 
Affect ratings. After each picture viewing trial participants rated their affect using a computerized 
9-point version of the Self-Assessment Manikin (SAM; [35]). Three sets of 9 human figures 
depicting gradually increasing pleasantness, arousal and control were presented and participants 
selected the figures that represented their level of pleasantness, arousal and control during the trial.  
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
1	  Positive1: 1463, 1920, 2550, 4574, 5201, 5260, 7330, 8030, 8080, 8185; Positive 2: 1620, 2341, 5700, 5760, 5849, 
7280, 8200, 8370, 8461, 8490; Positive 3: 1710, 2311, 2360, 5891, 7260, 8033, 8190, 8300, 8470, 8502; Negative1: 
1114, 2095, 2520, 2692, 2900.1, 5971, 6315, 6821, 9181, 9611; Negative2: 1525, 6190, 6242, 9001, 9410, 9425, 
9426, 9520, 9561, 9911; Negative3: 1932, 2800, 5972, 6300, 6370, 6800, 6838, 9041, 9140, 9421.   
2 Positive pleasantness ratings (1-9): M1= 7.50 SD1= 0.36, M2= 7.57 SD2=0.46, M3=7.55 SD3=0.60; Positive arousal 
ratings (1-9): M1= 5.39 SD1= 1.30, M2= 5.09 SD2=1.27, M3= 5.14 SD3=1.09; Negative pleasantness ratings (1-9): 
M1= 2.72 SD1= 0.79, M2= 2.58 SD2=0.65, M3=2.72 SD3=0.71; Negative arousal ratings (1-9): M1= 5.80 SD1= 
0.77, M2= 5.71 SD2=1.02, M3= 5.77 SD3=0.75.	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Symptom checklist. A 14-item list of physical symptoms was also completed after each trial. The 
checklist included a variety of symptoms (chest tightness, pounding of the heart, headache, 
fatigue, not able to breathe deeply, rapid heartbeat, dizziness, muscular pain, burning sensation in 
the eyes), previously used in a similar picture viewing paradigm [18], while gastrointestinal 
symptoms (abdominal or stomach cramps, regurgitations, nausea, abdominal pain, abdominal 
bloating) were added to examine the hypotheses of this study. Participants rated the presence of 
each symptom on a 5-point Likert scale (1=not at all, 5=very strong). Total scores (range: 14-70) 
were calculated and used in analyses.  
Besides total scores, analyses were also conducted for subsets of symptoms. Subsets were 
determined via principal component analysis of the symptom checklist, using data from a student 
sample (N=61, 7 males, Mage=18.90, SDage=1.25). The principal component analysis resulted in 
two subsets of symptoms3: a) four symptoms related to cardio-respiratory indicators of 
physiological arousal (chest tightness, pounding of the heart, not able to breathe deeply and rapid 
heartbeat; factor eigenvalue=3.15, Cronbach’s α=.75, total variance explained=22.47%) and b) 
four pain-related/gastrointestinal (GI) symptoms (headache, muscular pain, stomach/abdominal 
cramps and stomach pain; factor eigenvalue=2.16, Cronbach’s α=.70, total variance 
explained=15.45%). This structure was largely confirmed in the IBS patient group (N=29), 
although for the patients the second factor also included the item bloated stomach. Despite its 
small size, the patient group is considered more representative of the population of interest, thus 
the subsets computed for the analyses were: one with four arousal-related items and one with five 
pain/GI-related items as suggested by the patient sample.   
Group characteristics 
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
3A parallel analysis procedure [36] was first conducted to determine the number of reliable factors, which 
suggested a two-factor structure for the checklist. A principal component analysis (PCA) with varimax 
rotation and factor extraction constrained to two factors (KMO = .57; χ2 (91) = 242.61, p<.001) confirmed 
the two-factor structure, which could explain 37.91% of the variance. Items loading .60 or higher were 
retained for each of the two factors.  
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Habitual symptom reporting. The Checklist for Symptoms in Daily Life based on the checklist of 
Wientjes & Grossman [37] was administered to assess participants’ level of habitual symptom 
reporting. Participants reported how often they experienced 39 everyday symptoms from various 
modalities (e.g. headache, back pain) over the past year on a 5-point Likert Scale (1=never, 
5=very often). Total scores (ranging from 39 to 195) were calculated.  
Anxiety and depression. The Dutch version [38] of the Hospital Anxiety and Depression Scale 
(HADS; [39]) was used to assess participants’ level of anxiety and/or depression. The HADS 
consists of 14 questions, assessing anxiety and depressive feelings/symptoms over the past week 
on a 4-point Likert scale. Separate scores for anxiety and depression were calculated.   
Procedure 
Testing took place at the gastrointestinal unit of UZ Gasthuisberg during the outpatient 
consultations. Patients diagnosed with IBS were invited by their doctors to participate in a study 
“examining the effects of emotions on IBS”, whereas controls were invited to the clinic via email. 
Upon arrival to the testing room, participants gave written informed consent and completed a brief 
inventory assessing health status and demographic information and the Checklist for Symptoms in 
Daily Life.  
Next, participants were introduced to the three tasks of the modified Affect Labeling task. 
For the VIEW task, participants were instructed to merely view the pictures and allow natural 
responses to the pictures, while for LABEL EMOTION and LABEL CONTENT tasks they were 
asked to choose among two given labels the one most relevant to the picture.  
When participants had no further questions, the experimenter left the room and participants 
completed the six picture viewing trials. Each trial consisted of: a) a 3-sec presentation of a word 
cue signaling the task participants had to do (VIEW, LABEL EMOTION, LABEL CONTENT), b) 
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a 60-sec picture viewing period, and c) a 1.5 min inter-trial period, during which participants 
completed electronic affect ratings and the symptom checklist.  
The trials were semi-counterbalanced with 12 orders created in such a way that each of the 
6 trials was presented twice at a certain order position, while each pleasant/unpleasant picture set 
was presented four times for each task (view, label emotion, label content). Affect 4.0. [40] was 
used for programming the experiment, while testing was done on a 13-inch laptop computer.   
At the end of the experiment, participants received a set of questionnaires (including the 
HADS), which they had to complete at home and send back.  
Design and data analyses 
A Group (controls, patients) x Task (view, label content, label emotion) x Affective cue 
(positive, negative) repeated measures ANOVA design was used. Analyses were conducted on a) 
the affect ratings (pleasantness, arousal, control) as a manipulation check, b) the total symptom 
score, and c) the scores for arousal- and pain/GI-related symptom subsets. Significant interactions, 
and those related to a priori hypotheses were followed up with separate simple effect ANOVAs. 
For the manipulation checks, a significant main effect of Affective cue would denote successful 
manipulation of affect, while an Affective cue x Task interaction would denote the expected 
modulation of affect by labeling tasks. As for the main analyses, in order to examine our first 
hypothesis, i.e. whether unpleasant pictures induced changes in symptom reports differentially in 
patients and controls without any intervention, we examined the Affective cue x Group interaction 
for the View condition only with the α criterion adjusted to .016 (Bonferroni adjustment). To 
examine our second hypothesis, i.e. whether the two labeling tasks moderate the effects of 
unpleasant pictures differentially for patients and controls, the Affective cue x Task interaction 
was examined separately for each group, regardless of the higher order 3-way interaction (α 
adjusted to .025). Greenhouse-Geisser corrected p-values and epsilon are reported when the 
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sphericity assumption was violated. Analyses were conducted with STATISTICA 11.0 (Statsoft, 
Inc., Tulsa, OK). The principal component analysis procedures were run with SPSS 17.0.  
Results 
Descriptive statistics 
Table 1 presents means and SDs for each group on various characteristics. The groups 
differed as expected on habitual symptom reporting, anxiety and depression (Table 1). Within the 
patient group, 18 people were on medication to manage their IBS symptoms, one person was 
taking antidepressants, and one anxiolytics. One patient was receiving psychological treatment for 
IBS and two for non-IBS related reasons.  
Manipulation checks  
Analyses showed that picture viewing elicited the expected changes in perceived 
pleasantness, arousal and control in both groups, thus confirming the intended manipulation. 
Specifically main effects of Affective cue were observed for each measure with positive trials 
(with pleasant pictures) resulting in higher pleasantness (F(1,53) = 389.18, p <.0001, partial η2 = 
.88), lower arousal (F(1,53) = 50.53, p <.001, partial η2 = .49) and higher perceived control 
(F(1,52) = 43.58, p <.001, partial η2 = .46) compared to negative trials (with unpleasant pictures; 
see means in Table 2). 
Furthermore, the two labeling conditions tended to dampen these affective reactions, 
although the effect was mainly observed for pleasantness ratings. Specifically, a significant 
Affective cue x Task interaction was found for perceived pleasantness (F(2,106) = 18.16, p <.001, 
partial η2 = .26). Follow-up analyses showed that the two labeling conditions resulted in lower 
pleasantness compared to the view condition for positive trials, F(2,106) = 17.02, p <.001, partial 
η2 = .24, and content labeling resulted in less unpleasantness compared to the view condition for 
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negative trials, F(2,106) = 4.28, p <.05, partial η2 = .07 (Figure 1a). This interaction was highly 
significant for both groups (p<.0001). As for arousal and control ratings, the effects of Affective 
cue were not significantly moderated by Task (Figures 1b & 1c).  
Main analyses – Hypotheses testing 
Group effect. IBS patients reported overall more symptoms in total and more pain/GI 
symptoms than controls (F(1,52) = 6.04, p <.05, partial η2 = .10 and F(1,52) = 8.12, p <.01, partial 
η2 =.14 respectively). A main effect of Group was not observed for arousal symptoms.  
Affective cue effect. As expected, overall more symptoms were reported after negative than 
positive trials for the total symptom score, F(1,52) = 23.81, p <.001, partial η2 = .31, as well as the 
arousal and pain/GI subsets (F(1,52) = 25.47, p <.001, partial η2 = .33 and F(1,52) = 6.49, p <.05, 
partial η2 = .11 respectively). The Affective cue effect was not moderated by Group during the 
View condition for the total symptom score nor for pain/GI symptoms, although a nonsignificant 
trend emerged towards higher arousal symptom reports in IBS patients than controls after merely 
viewing negative compared to positive pictures, F(1,53) = 2.40, p =.11, partial η2 = .05.  
Labeling effects. For the total symptom scores, no Task effect or Affective cue x Task 
interaction was found for either group. Similarly, no Task effects were found for the pain/GI 
subset. However, for the arousal symptoms, a trend for an Affective cue x Task x Group 
interaction was observed, F(2,104) = 2.72, ε = .74, p =.09, partial η2 = .05. Separate analyses per 
group showed a trend towards an Affective cue x Task interaction for IBS patients (F(2,56) = 2.96, 
ε = .74, p =.08, partial η2 = .10). Follow-up analyses (paired-sample t-tests for each task) showed 
that for IBS patients the negative trials led to significantly more arousal symptoms than positive 
ones only during the View condition (t (28)= 4.03, p<.001), while the difference between positive 
and negative trials tended to reduce at the two labeling conditions (emotion labeling: t(28)=1.28, p 
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=.21, content labeling: t(28)=2.13, p=.04, Bonferroni adj.: p<.025). This trend was not observed in 
controls (Figure 2). 
Discussion 
Previous literature suggests that unpleasant cues augment symptom reporting, a bias that, 
according to data from a non-clinical sample, is reduced when people regulate their negative affect 
by verbally labeling these cues [31]. The present study aimed to extend prior findings by 
examining whether unpleasant cues increase momentary symptom reports in IBS patients and 
whether this can be reversed by applying an implicit emotion regulation strategy. To this end, 
patients diagnosed with IBS and healthy controls completed a modified Affect Labeling task, 
which included viewing pleasant and unpleasant pictures under a merely viewing condition, an 
emotion labeling or a non-emotional labeling condition, followed by a symptom checklist.  
Affect ratings after each trial confirmed that the pictures induced the expected affective 
reactions. Main analyses further showed that this affective manipulation modulated momentary 
symptom reports as unpleasant pictures led to overall elevated symptoms reports. Although the 
increase was rather small, this effect is in line with findings from studies with student populations 
[18,19], and it indicates that mild unpleasant stimulation can influence the reporting of physical 
symptoms in both non-clinical and patient samples. The current manipulation differs importantly 
from paradigms typically used in IBS research, as it does not use experimentally-induced 
physiological stimulation, e.g. by means of rectal distensions [10]. Rather, it assesses affective 
influences on self-reported symptoms with little actual physiological input and as such is highly 
relevant for patient groups experiencing symptoms unrelated to detectable physiological 
dysfunction. The fact that such a paradigm induced elevated symptom reporting in IBS patients 
adds to prior findings emphasizing the role of top-down schematic influences in the experience of 
symptoms in this group [41].  
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Nevertheless, the effect of unpleasant cues on symptom reports was not more pronounced 
in IBS patients, as initially hypothesized. Only for arousal symptoms, there was a tendency for 
unpleasant cues to result in more symptom reporting for IBS patients compared to controls. This 
lack of strong group differences on the effects of affective cues contradicts findings from non-
clinical samples showing more pronounced effects of unpleasant pictures for high habitual 
symptom reporters scoring high for trait NA [18,19], as well as research showing more profound 
effects of induced NA in the perception of visceral sensations in IBS patients [10,20]. A possible 
explanation for this discrepancy may be the rather mild affective manipulation used in our study. 
Most studies with patients have used rather intense emotion or stress inducing stimuli (auditory 
stress), which may suggest that patients are less susceptible to mild contextual cues. This implies 
that a more intense manipulation of state NA is needed for its differential effects on symptom 
reporting in a patient group compared to healthy controls to emerge.  
A second aim of this study was to examine whether affect labeling can reduce the effects of 
unpleasant pictures on symptom reporting. Manipulation checks indicated that the two labeling 
conditions dampened the affective reactions to the pictures, confirming the emotion regulatory 
function of both emotional and non-emotional labeling. However, labeling effects on affect ratings 
were not as pronounced as previously found [31]. This may be due to the fact that unpleasant 
pictures in this sample did not elicit very strong affective reactions. As a result, there may have not 
been enough room for robust labeling effects to emerge. As for the effects of labeling on symptom 
reports, current results provide only weak support for the hypothesis that labeling reduces 
symptom reporting during negative trials. The expected interaction between Task and Affective 
cue was not found for total symptom scores, while, when subsets of symptoms were explored, a 
tendency towards the expected pattern of data was observed only for the arousal-related 
symptoms. Specifically, both labeling conditions tended to reduce affective influences on arousal 
symptoms, as hypothesized, but only for IBS patients. The fact that this effect was more profound 
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in patients is in line with our hypothesis that patients, who are probably less able to spontaneously 
regulate emotional reactions in an effective way [21,42,43], can benefit more from emotion 
regulatory procedures. Even though the effect was rather small, it provides initial experimental 
data that can complement findings from clinical studies showing that emotion regulation 
techniques focused on the verbalization of affect, like expressive writing [44], and attentional 
control, like mindfulness [45-47], can reduce stress and symptom reports in IBS patients.        
However, it is important to note that affect labeling in our study did not influence pain/GI 
symptom reports. Thus, assigning labels to unpleasant stimuli attenuated slightly the experience of 
symptoms related to emotional arousal, but not of symptoms that characterize the condition of IBS 
patients. This may again be due to the mild affective manipulation and the subsequent limited 
labeling effects. Stronger manipulations may be required for situational influences to be observed 
on symptoms that are relevant and so pervasive into the lives of IBS patients.  
Besides the lack of a strong affective manipulation, other limitations should be noted. The 
reported symptoms during the experiment were rather low (at the lower end of the symptom scale), 
which is expected as the paradigm did not include the induction of physiological stimulation. 
However, this resulted in small changes on symptom reporting between conditions, which possibly 
reduced the strength of current findings. Furthermore, current findings were based solely on self-
reports, which can be influenced by participant expectations and demand characteristics. 
Recording physiological indices of emotional reactivity (e.g. heart rate, skin conductance) during 
picture viewing could confirm the intended affective manipulations and eliminate the possibility of 
mere reporting bias. Another issue is that the two groups differed in various parameters of socio-
economic status as well as in medication use (many IBS patients were using medication to control 
their symptoms), factors that could have confounded the results. Finally, the limited number of 
males in the sample did not allow for examining gender differences in the task, even though 
gender differences in symptom reporting in general have been systematically reported [48].      
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Further research using emotional stimuli that elicit stronger emotional reactions, like film 
clips or imagery, could delineate the trends seen in our study. Furthermore, IBS patients have more 
localized and specified symptoms, compared to other functional groups. Such specificity may be 
linked to less negative affect, as has been shown in the context of anxiety disorders [49]. Thus, 
future research should also examine the effectiveness of emotion regulation strategies in other 
groups of functional syndrome patients with more widespread symptomatology and possibly more 
overall emotional distress, like CFS or fibromyalgia. 
In conclusion, the present study replicated the augmenting effects of unpleasant cues on 
symptom reporting in a functional syndrome patient sample and provides initial indications that 
emotion regulatory processes, like labeling emotional cues, can reduce to some extent the affective 
biases on symptom perception, especially for functional syndrome patients. Further research is 
needed to explore the therapeutic role of such emotion regulation strategies in functional 
syndromes.   
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Table 1. Group differences in self-reported variables 
Measure Group - Mean (SD) t(df) 
 Controls Patients  
Age 36.50 (12.65) 37.55 (12.46) -0.31 (53) 
BMI 23.06 (3.41) 23.10 (4.09) -0.04 (53)  
CSD 61.81 (10.73) 83.83 (15.81) -5.97 (53)*** 
HADS-anxiety 4.19 (2.56) 8.21 (3.68) -4.51 (48)*** 
HADS-depression 4.15 (1.40) 7.04 (3.24) -4.15 (48)*** 
HADS-total 8.35(3.78) 15.25 (6.36) -4.71 (48)*** 
Note: ***p<.001 
BMI = Body Mass Index, CSD = Checklist for Symptoms in Daily Life, HADS = 
Hospital Anxiety and Depression Scale 
 
 
 
 
